News
In July 2025 alone, Wegovy clocked Rs 7 crore in sales with around 5,000 injections, while Mounjaro posted Rs 47 crore in ...
HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable ...
Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...
Indian pharmaceutical companies are preparing to launch generic versions of Novo Nordisk's weight-loss drug, semaglutide, potentially reducing its price by up to 80%.
Sales of Novo Nordisk's Wegovy and Eli Lilly's Mounjaro in India doubled in July, according to Pharmarack data. Wegovy, ...
Orforglipron showed clinically meaningful results at 72 weeks, after three doses, in a pool of more than 3000 adults.
Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2025 Earnings Conference Call. [Operator ...
Arterial Stents Market Prominent players in the market are Abbott Vascular, Biosensors International Group,, C. R. Bard, Inc. (BARD Periphe ...
Stock futures were rising again on the eve of another tariff deadline as investors juggled strong earnings with more signs of U.S. economic weakness. Shares closed in the red Tuesday after the ISM ...
As global demand for next-generation therapies on diabetes and weight loss surges, Indian pharmaceutical companies are ...
Hims & Hers stock dropped a sharp 11% after the company missed Q2 2025 revenue estimates, raising concerns about its booming ...
Shipping group Maersk raised its full-year profit forecast on Thursday as robust global container demand defied fears that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results